0 XP   0   0   0

Verastem Inc










Financial Health of Verastem




Comparing to competitors in the Biotechnology industry




  Industry Rankings  


Verastem Inc
Buy, Hold or Sell?

Should you buy, hold or sell Verastem?

I guess you are interested in Verastem Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Verastem

Let's start. I'm going to help you getting a better view of Verastem Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Verastem Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Verastem Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Verastem Inc. The closing price on 2022-12-02 was $0.4382 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Verastem Inc Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Verastem Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Verastem earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Verastem to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Verastem Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-919.4%+919.4%
TTM-919.4%YOY-287,025.1%+286,105.7%
TTM-919.4%5Y-57,967.0%+57,047.6%
5Y-57,967.0%10Y-28,983.5%-28,983.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--223.6%+223.6%
TTM-919.4%-281.7%-637.7%
YOY-287,025.1%-344.8%-286,680.3%
5Y-57,967.0%-450.1%-57,516.9%
10Y-28,983.5%-541.0%-28,442.5%
1.1.2. Return on Assets

Shows how efficient Verastem is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Verastem to the Biotechnology industry mean.
  • -16.3% Return on Assets means that Verastem generated $-0.16 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Verastem Inc:

  • The MRQ is -16.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -13.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-16.3%TTM-13.2%-3.1%
TTM-13.2%YOY-14.7%+1.5%
TTM-13.2%5Y-14.5%+1.3%
5Y-14.5%10Y-13.8%-0.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-16.3%-9.9%-6.4%
TTM-13.2%-8.9%-4.3%
YOY-14.7%-9.3%-5.4%
5Y-14.5%-11.7%-2.8%
10Y-13.8%-12.7%-1.1%
1.1.3. Return on Equity

Shows how efficient Verastem is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Verastem to the Biotechnology industry mean.
  • -28.8% Return on Equity means Verastem generated $-0.29 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Verastem Inc:

  • The MRQ is -28.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -23.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-28.8%TTM-23.2%-5.6%
TTM-23.2%YOY-18.7%-4.5%
TTM-23.2%5Y-57.4%+34.2%
5Y-57.4%10Y-36.3%-21.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-28.8%-12.0%-16.8%
TTM-23.2%-11.5%-11.7%
YOY-18.7%-10.8%-7.9%
5Y-57.4%-14.2%-43.2%
10Y-36.3%-15.2%-21.1%

1.2. Operating Efficiency of Verastem Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Verastem is operating .

  • Measures how much profit Verastem makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Verastem to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Verastem Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-918.4%+918.4%
TTM-918.4%YOY-187,143.2%+186,224.8%
TTM-918.4%5Y-37,927.3%+37,009.0%
5Y-37,927.3%10Y-18,963.7%-18,963.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.3%+207.3%
TTM-918.4%-271.0%-647.4%
YOY-187,143.2%-325.9%-186,817.3%
5Y-37,927.3%-454.0%-37,473.3%
10Y-18,963.7%-537.1%-18,426.6%
1.2.2. Operating Ratio

Measures how efficient Verastem is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Verastem Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM9.709-9.709
TTM9.709YOY1,893.431-1,883.722
TTM9.7095Y385.592-375.883
5Y385.59210Y192.796+192.796
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.871-2.871
TTM9.7093.504+6.205
YOY1,893.4313.604+1,889.827
5Y385.5925.132+380.460
10Y192.7966.371+186.425

1.3. Liquidity of Verastem Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Verastem is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.97 means the company has $4.97 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Verastem Inc:

  • The MRQ is 4.972. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.562. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.972TTM5.562-0.590
TTM5.562YOY9.075-3.512
TTM5.5625Y6.174-0.611
5Y6.17410Y9.446-3.273
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.9725.117-0.145
TTM5.5625.755-0.193
YOY9.0755.854+3.221
5Y6.1746.511-0.337
10Y9.4466.222+3.224
1.3.2. Quick Ratio

Measures if Verastem is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Verastem to the Biotechnology industry mean.
  • A Quick Ratio of 5.94 means the company can pay off $5.94 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Verastem Inc:

  • The MRQ is 5.937. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 7.950. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ5.937TTM7.950-2.013
TTM7.950YOY14.664-6.715
TTM7.9505Y8.391-0.441
5Y8.39110Y15.065-6.675
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.9374.284+1.653
TTM7.9504.664+3.286
YOY14.6644.787+9.877
5Y8.3915.218+3.173
10Y15.0655.182+9.883

1.4. Solvency of Verastem Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Verastem assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Verastem to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.43 means that Verastem assets are financed with 43.4% credit (debt) and the remaining percentage (100% - 43.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Verastem Inc:

  • The MRQ is 0.434. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.366. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.434TTM0.366+0.068
TTM0.366YOY0.238+0.128
TTM0.3665Y0.446-0.080
5Y0.44610Y0.274+0.173
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4340.278+0.156
TTM0.3660.277+0.089
YOY0.2380.306-0.068
5Y0.4460.367+0.079
10Y0.2740.403-0.129
1.4.2. Debt to Equity Ratio

Measures if Verastem is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Verastem to the Biotechnology industry mean.
  • A Debt to Equity ratio of 76.7% means that company has $0.77 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Verastem Inc:

  • The MRQ is 0.767. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.617. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.767TTM0.617+0.150
TTM0.617YOY0.312+0.305
TTM0.6175Y2.090-1.473
5Y2.09010Y1.106+0.984
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7670.315+0.452
TTM0.6170.317+0.300
YOY0.3120.319-0.007
5Y2.0900.403+1.687
10Y1.1060.462+0.644

2. Market Valuation of Verastem Inc

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Verastem generates.

  • Above 15 is considered overpriced but always compare Verastem to the Biotechnology industry mean.
  • A PE ratio of -9.87 means the investor is paying $-9.87 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Verastem Inc:

  • The EOD is -5.089. Company is losing money. -2
  • The MRQ is -9.872. Company is losing money. -2
  • The TTM is -16.142. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-5.089MRQ-9.872+4.783
MRQ-9.872TTM-16.142+6.271
TTM-16.142YOY-34.010+17.867
TTM-16.1425Y-26.370+10.228
5Y-26.37010Y-71.436+45.066
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.089-8.986+3.897
MRQ-9.872-9.792-0.080
TTM-16.142-16.243+0.101
YOY-34.010-20.876-13.134
5Y-26.370-16.665-9.705
10Y-71.436-14.732-56.704
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Verastem.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Verastem Inc:

  • The MRQ is -46.240. Very Bad. -2
  • The TTM is 137.537. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ-46.240TTM137.537-183.777
TTM137.537YOY118.293+19.244
TTM137.5375Y17.794+119.743
5Y17.79410Y-135.630+153.424
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-46.240-0.032-46.208
TTM137.5370.004+137.533
YOY118.2930.016+118.277
5Y17.7940.006+17.788
10Y-135.6300.003-135.633

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Verastem is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.84 means the investor is paying $2.84 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Verastem Inc:

  • The EOD is 1.464. Good. +1
  • The MRQ is 2.840. Good. +1
  • The TTM is 4.088. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD1.464MRQ2.840-1.376
MRQ2.840TTM4.088-1.248
TTM4.088YOY6.432-2.344
TTM4.0885Y8.744-4.656
5Y8.74410Y11.786-3.042
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.4641.835-0.371
MRQ2.8402.006+0.834
TTM4.0882.774+1.314
YOY6.4323.453+2.979
5Y8.7442.713+6.031
10Y11.7862.402+9.384
2. Total Gains per Share

2.4. Latest News of Verastem Inc

Does Verastem Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Verastem Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2022-11-08
14:22
Verastem Third Quarter 2022 Earnings: US$0.092 loss per share (vs US$0.13 loss in 3Q 2021)Read

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Verastem Inc.

3.1. Institutions holding Verastem Inc

Institutions are holding 53.739% of the shares of Verastem Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-06-30Baker Bros Advisors LP12.85190.17762698889800
2022-06-30Bvf Inc9.51171.1191997465800
2022-06-30Viking Global Investors LP4.39240.0489922400092240000
2022-06-30Vanguard Group Inc3.80170.00037983491-821395-9.3289
2022-06-30Eagle Asset Management, Inc.2.65320.0405557163394228020.3545
2022-06-30Millennium Management LLC2.45450.003751545304158108417.3039
2022-06-30MPM Oncology Impact Management LP1.54511.0456324465000
2022-06-30Altium Capital Management, LP1.42861.39253000000490001.6605
2022-06-30Armistice Capital, LLC0.95240.0405200000000
2022-06-30Artisan Partners Limited Partnership0.91370.00381918768-25363-1.3046
2022-06-30Geode Capital Management, LLC0.85360.00031792564-1349539-42.9502
2022-06-30Soleus Capital Management, L.P.0.78310.2977164450000
2022-06-30Opaleye Management Inc0.75710.83121590000-735000-31.6129
2022-06-30UBS O'Connor LLC0.67950.0291426983786983122.9661
2022-06-30Dimensional Fund Advisors, Inc.0.6510.00061367051-492902-26.5008
2022-06-30Two Sigma Advisers, LLC0.50170.00351053600-567200-34.9951
2022-06-30PURA VIDA INVESTMENTS, LLC0.47820.0677100427210042720
2022-06-30Clarivest Asset Management LLC0.41970.044688139510240013.1451
2022-06-30Ergoteles LLC0.39620.0289832015628590309.0033
2022-06-30State Street Corporation0.33430.0001702078-2403583-77.3936
Total 46.35965.17697355086+10500651+10.8%

3.2. Funds holding Verastem Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-09-30Vanguard Instl Ttl Stck Mkt Idx Tr2.7060.000556825714782599.1897
2022-10-31Vanguard Total Stock Mkt Idx Inv2.7060.0002568257100
2022-09-30Carillon Eagle Small Cap Growth A1.46470.27273075943-265089-7.9343
2022-10-31Vanguard Extended Market Index Investor1.1930.0013250523000
2022-09-30Eagle Small Cap Growth – Institutional0.98070.14482059479598932.9953
2022-10-31iShares Biotechnology ETF0.66040.0072138682466360.4808
2022-09-30Artisan Non-U.S. Small-Mid Growth Comp0.59350.0267124635100
2022-09-30Artisan International Small-Mid Investor0.59350.0267124635100
2022-07-31MEDICAL BioHealth EUR Acc0.55240.1928116000000
2022-09-30Fidelity® Extended Market Index0.46690.00398041100
2022-09-30ClariVest Smid Cap Growth0.23230.229748780016730052.1997
2022-09-30APO Medical Opportunities R0.2010.044342200000
2022-10-31iShares Micro-Cap ETF0.17960.017337715300
2022-06-30BlackRock Extended Mkt Composite0.15890.00333336833336830
2022-09-30BlackRock Extended Equity Market K0.14030.0024294621-2714-0.9128
2022-07-31Old Westbury Small & Mid Cap Strategies0.13390.004128123400
2022-09-30Fidelity® Total Market Index0.12940.000427174200
2022-03-31iShares Russell 2000 Small-Cap Idx Instl0.12280.008625779200
2022-09-30Fidelity® Series Total Market Index0.10030.000421065800
2022-07-31RIM Global Bioscience EUR0.08620.213518100000
Total 13.40181.199928143414+777968+2.8%

3.3. Insider Transactions

Insiders are holding 0.902% of the shares of Verastem Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-09-19Dan PatersonSELL27861.13482458
2022-09-19Robert E GagnonSELL13481.13588554
2022-09-19Brian M StuglikSELL33551.131151238
2022-08-01Brian M StuglikSELL58581.081154593
2022-06-21Brian M StuglikSELL33621.141160451
2022-06-21Dan PatersonSELL27011.14485244
2022-06-21Robert E GagnonSELL13511.14589902
2022-05-02Brian M StuglikSELL58571.411127607
2022-03-21Robert E GagnonSELL14091.27
2022-03-21Dan PatersonSELL28181.27
2022-03-21Brian M StuglikSELL35071.27
2022-01-31Brian M StuglikSELL56951.48
2021-12-20Brian M StuglikSELL136822.27
2021-12-20Dan PatersonSELL109942.27
2021-12-20Robert E GagnonSELL54972.27
2020-12-04Timothy J BarberichBUY500002.17218000
2020-06-25Ra Capital Management, L.p.SELL11613001.91
2020-04-27Ra Capital Management, L.p.SELL13013002.31
2019-03-15Timothy J BarberichBUY330003.21168000
2018-09-28Joseph M LobackiBUY30007.310700

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Verastem Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.043-0.039+191%-0.041+195%0.005+721%-0.004+109%
Book Value Growth--0.143-0.126+188%-0.086+160%-0.195+237%-0.126+188%
Book Value Per Share--0.2990.330-9%0.467-36%0.395-24%0.416-28%
Book Value Per Share Growth--0.143-0.126+188%-0.086+160%-0.195+237%-0.126+188%
Current Ratio--4.9725.562-11%9.075-45%6.174-19%9.446-47%
Debt To Asset Ratio--0.4340.366+19%0.238+82%0.446-3%0.274+59%
Debt To Equity Ratio--0.7670.617+24%0.312+146%2.090-63%1.106-31%
Dividend Per Share----0%-0%-0%-0%
Eps---0.086-0.087+2%-0.089+3%-0.104+20%-0.081-6%
Eps Growth--0.2130.085+151%-0.427+300%0.124+73%0.051+316%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin----9.1940%-2870.2510%-579.6700%-289.8350%
Operating Margin----9.1840%-1871.4320%-379.2730%-189.6370%
Operating Ratio---9.709-100%1893.431-100%385.592-100%192.796-100%
Pb Ratio1.464-94%2.8404.088-31%6.432-56%8.744-68%11.786-76%
Pe Ratio-5.089+48%-9.872-16.142+64%-34.010+245%-26.370+167%-71.436+624%
Peg Ratio---46.240137.537-134%118.293-139%17.794-360%-135.630+193%
Price Per Share0.438-94%0.8501.368-38%2.938-71%2.668-68%4.566-81%
Price To Total Gains Ratio10.251-94%19.884-16.564+183%-33.238+267%-14.432+173%-1135.356+5810%
Profit Growth--21.34934513.722-100%-42.720+300%6913.394-100%3455.649-99%
Quick Ratio--5.9377.950-25%14.664-60%8.391-29%15.065-61%
Return On Assets---0.163-0.132-19%-0.147-10%-0.145-11%-0.138-15%
Return On Equity---0.288-0.232-19%-0.187-35%-0.574+99%-0.363+26%
Total Gains Per Share--0.043-0.039+191%-0.041+195%0.005+721%-0.004+109%
Total Gains Per Share Growth--3.1020.128+2320%1.484+109%-0.409+113%5.240-41%
Usd Book Value--62873000.00069273750.000-9%98187000.000-36%82922250.000-24%87450025.000-28%
Usd Book Value Change Per Share--0.043-0.039+191%-0.041+195%0.005+721%-0.004+109%
Usd Book Value Per Share--0.2990.330-9%0.467-36%0.395-24%0.416-28%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.086-0.087+2%-0.089+3%-0.104+20%-0.081-6%
Usd Price Per Share0.438-94%0.8501.368-38%2.938-71%2.668-68%4.566-81%
Usd Profit---18090000.000-14255120.250-21%-18645750.000+3%-20967174.050+16%-16642587.025-8%
Usd Revenue---649136.250-100%503500.000-100%6839677.250-100%3419838.625-100%
Usd Total Gains Per Share--0.043-0.039+191%-0.041+195%0.005+721%-0.004+109%
 EOD+2 -3MRQTTM+15 -14YOY+17 -125Y+19 -1010Y+13 -16

4.2. Fundamental Score

Let's check the fundamental score of Verastem Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.089
Price to Book Ratio (EOD)Between0-11.464
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than15.937
Current Ratio (MRQ)Greater than14.972
Debt to Asset Ratio (MRQ)Less than10.434
Debt to Equity Ratio (MRQ)Less than10.767
Return on Equity (MRQ)Greater than0.15-0.288
Return on Assets (MRQ)Greater than0.05-0.163
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Verastem Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.430
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets111,095
Total Liabilities48,222
Total Stockholder Equity62,873
 As reported
Total Liabilities 48,222
Total Stockholder Equity+ 62,873
Total Assets = 111,095

Assets

Total Assets111,095
Total Current Assets108,759
Long-term Assets108,759
Total Current Assets
Cash And Cash Equivalents 78,166
Short-term Investments 25,810
Net Receivables 74
Other Current Assets 4,709
Total Current Assets  (as reported)108,759
Total Current Assets  (calculated)108,759
+/-0
Long-term Assets
Property Plant Equipment 2,048
Other Assets 288
Long-term Assets  (as reported)2,336
Long-term Assets  (calculated)2,336
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities21,873
Long-term Liabilities26,349
Total Stockholder Equity62,873
Total Current Liabilities
Short-term Debt 761
Accounts payable 5,359
Other Current Liabilities 15,753
Total Current Liabilities  (as reported)21,873
Total Current Liabilities  (calculated)21,873
+/-0
Long-term Liabilities
Long term Debt Total 24,667
Capital Lease Obligations Min Short Term Debt1,682
Long-term Liabilities  (as reported)26,349
Long-term Liabilities  (calculated)26,349
+/-0
Total Stockholder Equity
Common Stock21
Retained Earnings -720,715
Accumulated Other Comprehensive Income -39
Capital Surplus 783,606
Total Stockholder Equity (as reported)62,873
Total Stockholder Equity (calculated)62,873
+/-0
Other
Capital Stock21
Cash and Short Term Investments 103,976
Common Stock Shares Outstanding 197,151
Common Stock Total Equity21
Liabilities and Stockholders Equity 111,095
Net Debt -75,455
Net Invested Capital 87,540
Net Tangible Assets 62,873
Net Working Capital 86,886
Short Long Term Debt Total 2,711



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-31
> Total Assets 
3,604
0
0
62,767
59,037
110,705
105,664
98,830
92,923
86,241
79,961
132,429
125,261
115,726
107,342
97,883
98,649
142,003
135,696
123,666
113,094
102,564
95,423
89,044
83,629
76,249
61,839
63,139
89,791
68,411
172,918
183,155
277,236
243,365
218,541
192,600
145,046
208,154
198,532
217,770
145,354
136,901
123,890
111,877
108,662
116,148
100,409
111,095
111,095100,409116,148108,662111,877123,890136,901145,354217,770198,532208,154145,046192,600218,541243,365277,236183,155172,91868,41189,79163,13961,83976,24983,62989,04495,423102,564113,094123,666135,696142,00398,64997,883107,342115,726125,261132,42979,96186,24192,92398,830105,664110,70559,03762,767003,604
   > Total Current Assets 
0
0
0
61,830
47,941
41,557
39,197
47,281
57,082
67,709
58,292
101,007
101,955
106,585
99,558
94,476
95,316
134,872
132,744
121,181
110,843
100,537
93,533
87,313
81,295
74,005
59,753
61,204
87,787
66,030
170,437
158,729
253,259
216,596
192,346
166,958
84,961
148,646
144,592
188,555
144,938
127,678
114,760
108,757
105,740
113,439
97,875
108,759
108,75997,875113,439105,740108,757114,760127,678144,938188,555144,592148,64684,961166,958192,346216,596253,259158,729170,43766,03087,78761,20459,75374,00581,29587,31393,533100,537110,843121,181132,744134,87295,31694,47699,558106,585101,955101,00758,29267,70957,08247,28139,19741,55747,94161,830000
       Cash And Cash Equivalents 
3,584
0
0
61,824
20,954
25,470
15,751
11,126
10,096
28,245
13,880
22,640
18,889
13,244
22,391
20,557
33,901
30,125
35,172
19,831
24,870
15,147
39,564
37,274
32,349
28,179
27,583
51,270
82,176
64,215
168,692
130,727
129,867
91,525
113,080
103,320
43,514
135,061
125,328
170,470
67,782
35,514
24,972
24,314
21,252
46,687
63,950
78,166
78,16663,95046,68721,25224,31424,97235,51467,782170,470125,328135,06143,514103,320113,08091,525129,867130,727168,69264,21582,17651,27027,58328,17932,34937,27439,56415,14724,87019,83135,17230,12533,90120,55722,39113,24418,88922,64013,88028,24510,09611,12615,75125,47020,95461,824003,584
       Short-term Investments 
0
0
0
0
26,857
15,597
22,937
35,726
46,480
38,478
43,571
77,290
82,423
92,398
76,204
72,809
58,774
101,946
96,921
100,636
85,388
84,388
53,302
49,608
48,548
44,392
30,335
8,994
4,496
4,496
161
14,912
119,786
120,134
74,173
56,908
31,992
31,992
0
0
73,444
85,583
83,163
79,102
79,004
59,591
30,357
25,810
25,81030,35759,59179,00479,10283,16385,58373,4440031,99231,99256,90874,173120,134119,78614,9121614,4964,4968,99430,33544,39248,54849,60853,30284,38885,388100,63696,921101,94658,77472,80976,20492,39882,42377,29043,57138,47846,48035,72622,93715,59726,8570000
       Net Receivables 
0
0
0
0
0
0
133
0
161
161
0
0
123
123
0
0
2,348
2,348
0
0
154
154
0
0
204
204
0
0
0
0
0
10,562
306
558
1,389
2,203
2,524
3,326
1,500
5,685
239
1,125
476
105
516
2,644
131
74
741312,6445161054761,1252395,6851,5003,3262,5242,2031,38955830610,5620000020420400154154002,3482,34800123123001611610133000000
       Inventory 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
131
327
306
294
478
3,096
4,372
6,316
0
0
0
0
0
0
0
0
0
0000000006,3164,3723,0964782943063271310000000000000000000000000000000
   > Long-term Assets 
0
0
0
937
11,096
69,148
66,467
51,549
35,841
18,532
21,669
31,422
23,306
9,141
7,784
3,407
3,333
7,131
2,952
2,485
2,251
2,027
1,890
1,731
2,334
2,244
2,086
1,935
2,004
2,381
2,481
24,426
23,977
26,769
26,195
25,642
60,085
59,508
53,940
29,215
416
9,223
9,130
3,120
2,922
2,709
2,534
2,336
2,3362,5342,7092,9223,1209,1309,22341629,21553,94059,50860,08525,64226,19526,76923,97724,4262,4812,3812,0041,9352,0862,2442,3341,7311,8902,0272,2512,4852,9527,1313,3333,4077,7849,14123,30631,42221,66918,53235,84151,54966,46769,14811,096937000
       Property Plant Equipment 
8
0
0
719
709
793
782
884
811
755
730
674
631
577
1,489
2,885
2,825
2,645
2,456
2,282
2,048
1,865
1,728
1,569
1,417
1,271
1,127
989
861
1,003
1,270
1,210
1,369
4,559
4,374
4,187
4,024
3,861
3,700
3,317
416
2,963
2,794
2,656
2,512
2,363
2,209
2,048
2,0482,2092,3632,5122,6562,7942,9634163,3173,7003,8614,0244,1874,3744,5591,3691,2101,2701,0038619891,1271,2711,4171,5691,7281,8652,0482,2822,4562,6452,8252,8851,489577631674730755811884782793709719008
       Long Term Investments 
0
0
0
0
0
68,269
65,599
50,579
34,944
17,691
20,558
30,340
22,344
8,234
5,757
0
0
4,001
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,995
5,998
5,992
0
0
0
0
0
000005,9925,9985,99500000000000000000000004,001005,7578,23422,34430,34020,55817,69134,94450,57965,59968,26900000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21,969
21,577
21,185
20,793
20,400
20,008
19,616
19,223
0
0
0
0
0
0
0
0
0
00000000019,22319,61620,00820,40020,79321,18521,57721,9690000000000000000000000000000000
       Other Assets 
0
0
0
218
10,387
68,355
65,685
50,665
35,030
17,777
20,939
30,748
22,675
8,564
6,295
522
508
4,486
496
203
203
162
162
162
917
973
959
946
1,143
1,378
1,211
1,247
1,031
1,025
1,028
1,055
36,053
36,031
31,017
25,898
8,995
262
344
464
410
346
325
288
2883253464104643442628,99525,89831,01736,03136,0531,0551,0281,0251,0311,2471,2111,3781,1439469599739171621621622032034964,4865085226,2958,56422,67530,74820,93917,77735,03050,66565,68568,35510,387218000
> Total Liabilities 
368
0
0
2,125
71,803
3,030
3,295
3,218
2,457
3,410
5,270
5,724
7,815
6,401
8,163
9,072
9,883
10,098
10,435
11,423
10,625
6,596
6,355
6,608
11,332
15,777
13,607
22,154
32,107
29,859
46,051
75,542
152,937
154,905
169,234
171,083
137,872
85,171
84,159
87,997
39,075
34,292
35,685
16,222
21,103
43,377
46,517
48,222
48,22246,51743,37721,10316,22235,68534,29239,07587,99784,15985,171137,872171,083169,234154,905152,93775,54246,05129,85932,10722,15413,60715,77711,3326,6086,3556,59610,62511,42310,43510,0989,8839,0728,1636,4017,8155,7245,2703,4102,4573,2183,2953,03071,8032,12500368
   > Total Current Liabilities 
368
0
0
2,008
3,146
2,937
3,213
3,149
2,399
3,364
5,238
5,706
7,804
6,392
7,871
8,385
9,204
9,461
9,837
10,864
10,109
6,124
5,925
6,220
10,991
13,233
11,066
19,618
17,128
14,845
22,132
53,441
37,077
28,624
31,204
30,510
29,890
25,728
28,784
37,678
17,093
11,844
12,744
13,536
18,590
16,886
20,092
21,873
21,87320,09216,88618,59013,53612,74411,84417,09337,67828,78425,72829,89030,51031,20428,62437,07753,44122,13214,84517,12819,61811,06613,23310,9916,2205,9256,12410,10910,8649,8379,4619,2048,3857,8716,3927,8045,7065,2383,3642,3993,1493,2132,9373,1462,00800368
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,249
2,293
2,335
14,828
14,913
1,384
3,528
5,716
203
294
379
420
485
5,094
9,833
558
583
610
638
667
696
728
761
7617286966676386105835589,8335,0944854203792942035,7163,5281,38414,91314,8282,3352,2932,2490000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,249
2,293
2,335
14,828
14,913
1,384
3,528
5,716
203
0
0
0
0
4,586
9,300
0
0
0
0
0
0
0
0
000000009,3004,58600002035,7163,5281,38414,91314,8282,3352,2932,2490000000000000000000000000
       Accounts payable 
279
0
0
1,246
2,273
1,936
2,450
1,737
1,848
1,926
2,034
1,836
2,760
2,515
3,159
3,299
3,216
3,951
2,999
3,646
3,942
2,595
2,149
1,962
4,095
8,809
6,825
7,363
9,186
7,267
8,514
11,249
10,253
8,593
11,538
8,842
9,655
7,233
2,241
4,681
1,875
2,453
1,395
641
2,302
2,896
1,706
5,359
5,3591,7062,8962,3026411,3952,4531,8754,6812,2417,2339,6558,84211,5388,59310,25311,2498,5147,2679,1867,3636,8258,8094,0951,9622,1492,5953,9423,6462,9993,9513,2163,2993,1592,5152,7601,8362,0341,9261,8481,7372,4501,9362,2731,24600279
       Other Current Liabilities 
89
0
0
762
873
1,001
763
1,412
551
1,438
3,204
3,870
5,044
3,877
4,712
5,086
5,988
5,510
6,838
7,218
6,167
3,529
3,776
4,258
6,896
4,424
4,241
12,255
7,942
7,578
12,234
38,664
21,108
19,828
19,372
21,289
19,815
18,010
21,449
23,164
14,660
8,808
10,739
12,257
15,621
13,294
17,658
15,753
15,75317,65813,29415,62112,25710,7398,80814,66023,16421,44918,01019,81521,28919,37219,82821,10838,66412,2347,5787,94212,2554,2414,4246,8964,2583,7763,5296,1677,2186,8385,5105,9885,0864,7123,8775,0443,8703,2041,4385511,4127631,0018737620089
   > Long-term Liabilities 
0
0
0
117
68,657
93
82
69
58
46
32
18
11
9
292
687
679
637
598
559
516
472
430
388
341
2,544
2,541
2,536
14,979
15,014
23,919
22,101
115,860
126,281
138,030
140,573
107,982
59,443
55,375
50,319
21,982
22,448
22,941
2,686
2,513
26,491
26,425
26,349
26,34926,42526,4912,5132,68622,94122,44821,98250,31955,37559,443107,982140,573138,030126,281115,86022,10123,91915,01414,9792,5362,5412,5443413884304725165595986376796872929111832465869829368,657117000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,249
2,293
2,335
14,828
14,913
23,520
21,535
114,737
121,973
133,836
136,131
103,623
55,214
51,280
47,238
19,051
19,672
20,326
243
249
24,412
24,538
24,667
24,66724,53824,41224924320,32619,67219,05147,23851,28055,214103,623136,131133,836121,973114,73721,53523,52014,91314,8282,3352,2932,2490000000000000000000000000
       Other Liabilities 
0
0
0
117
516
93
82
69
58
46
32
18
11
9
292
687
679
637
598
559
516
472
430
388
341
295
248
201
151
101
399
566
1,123
500
500
870
870
870
870
0
0
0
0
0
0
0
0
0
0000000008708708708705005001,12356639910115120124829534138843047251655959863767968729291118324658698293516117000
       Deferred Long Term Liability 
0
0
0
0
0
66
57
47
38
28
16
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000016283847576600000
> Total Stockholder Equity
3,236
0
0
60,642
-12,766
107,675
102,369
95,612
90,466
82,831
74,691
126,705
117,446
109,325
99,179
88,811
88,766
131,905
125,261
112,243
102,469
95,968
89,068
82,436
72,297
60,472
48,232
40,985
57,684
38,552
126,867
107,613
124,299
88,460
49,307
21,517
7,174
122,983
114,373
129,773
115,274
102,609
88,205
95,655
87,559
72,771
53,892
62,873
62,87353,89272,77187,55995,65588,205102,609115,274129,773114,373122,9837,17421,51749,30788,460124,299107,613126,86738,55257,68440,98548,23260,47272,29782,43689,06895,968102,469112,243125,261131,90588,76688,81199,179109,325117,446126,70574,69182,83190,46695,612102,369107,675-12,76660,642003,236
   Common Stock
1
0
0
1
1
2
2
2
2
2
2
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
4
5
5
7
7
7
7
7
7
8
16
17
17
17
17
17
18
19
19
19
21
21191919181717171717168777777554444444444433333322222211001
   Retained Earnings Total Equity-720,715-702,625-680,673-663,711-647,230-624,444-607,542-592,511-572,647-585,785-562,800-524,785-486,011-455,872-413,678-375,576-364,227-342,559-324,192-303,142-284,907-261,781-248,345-235,323-223,668-215,746-207,177-198,883-187,020-171,575-156,198-141,018-127,069-113,736-100,715-87,653-76,329-65,738-55,488-46,451-38,530-28,163-21,33800000
   Accumulated Other Comprehensive Income 
0
0
0
-8,462
-14,469
-21,383
-28,174
-38,508
22
18
-3
80
28
22
29
26
11
39
32
44
43
135
77
60
29
12
-5
2
-2
-2,755
4
2
127
110
86
27
14
9
0
0
53
34
39
27
34
-113
-130
-39
-39-130-113342739345300914278611012724-2,755-22-51229607713543443239112629222880-31822-38,508-28,174-21,383-14,469-8,462000
   Capital Surplus 
0
0
0
0
0
129,056
130,541
134,118
136,893
138,299
140,430
202,951
205,068
210,015
212,883
215,851
229,770
288,060
296,800
299,215
301,305
303,006
304,733
306,040
307,587
308,801
310,014
325,886
360,823
362,739
469,415
471,831
499,741
502,021
505,086
507,494
531,937
685,733
700,141
702,403
707,715
710,100
712,593
742,840
751,217
753,538
756,628
783,606
783,606756,628753,538751,217742,840712,593710,100707,715702,403700,141685,733531,937507,494505,086502,021499,741471,831469,415362,739360,823325,886310,014308,801307,587306,040304,733303,006301,305299,215296,800288,060229,770215,851212,883210,015205,068202,951140,430138,299136,893134,118130,541129,05600000
   Treasury Stock000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
69,103
-66,439
129,056
130,541
134,118
136,893
138,299
140,430
202,951
205,068
210,015
212,883
215,851
229,770
288,060
296,800
299,215
301,305
303,006
304,733
306,040
307,587
308,801
310,014
325,886
360,823
362,739
469,415
471,831
499,741
502,021
505,086
507,494
531,937
685,733
700,141
702,403
115,204
710,100
712,593
742,840
751,217
753,538
756,628
783,606
783,606756,628753,538751,217742,840712,593710,100115,204702,403700,141685,733531,937507,494505,086502,021499,741471,831469,415362,739360,823325,886310,014308,801307,587306,040304,733303,006301,305299,215296,800288,060229,770215,851212,883210,015205,068202,951140,430138,299136,893134,118130,541129,056-66,43969,103000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.